文献速递牙周病

在侵袭性(III/IV期C级)牙周炎患者中,龈下刮治联合3天或7天全身抗生素的临床、微生物学及免疫学效应:一项随机安慰剂对照临床试验

Clinical, microbiological, and immunological effects of 3- or 7-day systemic antibiotics adjunctive to subgingival instrumentation in patients with aggressive (Stage III/IV Grade C) periodontitis: A randomized placebo-controlled clinical trial.
PubMed 文献 · J Clin Periodontol · 2022-08-21

纳入50例全身健康的侵袭性牙周炎(III/IV期C级)患者,龈下刮治后随机接受阿莫西林和甲硝唑500 mg每日3次×3天+安慰剂4天(A组,n=25)或同剂量×7天(B组,n=25)。6个月时A组残余PD≥6 mm位点数非劣于B组(ITT 95%CI上限1.050,PP 1.318,均低于预设界值Δ=3.1),两组临床、微生物及免疫学改善相当(p>.05),A组不良事件更少。

要点

  • 3天与7天阿莫西林+甲硝唑方案在6个月时残余PD≥6 mm位点数上非劣效。
  • 两组临床指标、牙周致病菌及促炎标志物均显著降低且组间无差异(p>.05)。
  • 3天方案不良事件更少,作者认为可能获得非劣效临床结局。

核心结论

  • 在侵袭性牙周炎(III/IV期C级)患者中,龈下刮治后辅以3天全身阿莫西林和甲硝唑可能获得6个月非劣效临床结局且不良事件少于7天方案。

研究设计与样本

  • 随机安慰剂对照临床试验,纳入50例全身健康侵袭性牙周炎(III/IV期C级)患者(32.7±4.3岁),龈下刮治后随机分为A组(n=25)和B组(n=25)。
  • A组:阿莫西林和甲硝唑500 mg每日3次×3天,随后安慰剂每日3次×4天;B组:同剂量抗生素每日3次×7天。
  • 基线、3个月和6个月评估临床、微生物及免疫学指标,2周后评估患者相关结局;主要结局为6个月时残余PD≥6 mm位点数。

主要发现

  • 主要结局:6个月残余PD≥6 mm位点数,ITT分析95%CI上限为1.050,PP分析95%CI上限为1.318,均低于预设界值Δ=3.1,拒绝无效假设,证明3天方案非劣于7天方案。
  • 两组所有临床参数改善相当(p>.05)。
  • 所有检测的牙周致病菌及促炎宿主标志物均显著降低,组间无差异(p>.05)。
  • A组不良事件少于B组。

临床怎么用

  • 作者认为,在侵袭性牙周炎(III/IV期C级)患者中,龈下刮治后辅以3天全身阿莫西林和甲硝唑可能获得6个月非劣效临床结局且不良事件更少。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To evaluate the clinical non-inferiority of a 3-day protocol of systemic antibiotics adjunctive to subgingival instrumentation (SI) compared with a 7-day-protocol in patients with Stage III/IV Grade C periodontitis. MATERIALS AND METHODS: Fifty systemically healthy patients (32.7 ± 4.3 years) with aggressive periodontitis (AgP; Stage III/IV Grade C periodontitis) were treated by SI and adjunctive amoxicillin and metronidazole and were randomly assigned to Group A: (n = 25) 500 mg antibiotics (AB) 3 times a day for 3 days, followed by placebo 3 times a day for 4 days, or Group B: (n = 25) 500 mg AB 3 times a day for 7 days. Clinical, microbial, and immunological parameters were assessed at baseline, 3 months, and 6 months, and patient-related outcomes were assessed after 2 weeks. The primary outcome variable was the number of residual sites with pocket depth (PD) ≥6 mm at 6 months. RESULTS: For the primary outcome variable (the number of residual sites with PD ≥6 mm at 6 months), the null hypothesis was rejected and non-inferiority of the 3-day AB protocol compared with the 7-day AB protocol was demonstrated (the upper limits of the 95% confidence interval for intention to treat analysis: [-2.572; 1.050] and per protocol analysis: [-2.523; 1.318] were lower than the assumed margin of Δ = 3.1). Comparable clinical improvements were obtained for all parameters with both antibiotic protocols (p > .05). All investigated periodontopathogens and pro-inflammatory host-derived markers were statistically significantly reduced without differences between the treatments (p > .05). CONCLUSIONS: These findings indicate that in patients with AgP (Stage III/IV Grade C periodontitis), a 3-day systemic administration of amoxicillin and metronidazole adjunctive to SI may lead to non-inferior clinical outcomes after 6-months with fewer adverse events compared with a 7-day-protocol.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Cosgarea R, Jepsen S, Heumann C, et al. Clinical, microbiological, and immunological effects of 3- or 7-day systemic antibiotics adjunctive to subgingival instrumentation in patients with aggressive (Stage III/IV Grade C) periodontitis: A randomized placebo-controlled clinical trial. J Clin Periodontol. 2022. PMID: 35781888. doi:10.1111/jcpe.13676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。